PBM/Manufacturer Deals May Skirt Medicaid Rebate Law - Prosecutor
Federal prosecutors may take an interest in manufacturer/pharmacy benefits management company contracts that could be interpreted as efforts to circumvent the Medicaid rebate law, Philadelphia Assistant U.S. Attorney James Sheehan indicated Dec. 17 at the Food and Drug Law Institute annual meeting in Washington, DC.
You may also be interested in...
The Medco "whistleblower" cases indicate the extent to which participants in the pharmaceutical sector are vulnerable to False Claims Act cases
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011